Although exercise may increase risk of hypoglycemia, only the individuals under insulin or insulin secretagogues (sulfonylureas and meglitinides) therapy seem to be at risk during, immediately after, or several hours after exercise. The gene discussed is INS; the disease is Hypoglycemia.